Posts by: Joana Fernandes, PhD

Joana Fernandes, PhD

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

November 23, 2016November 23, 2016

Enzyme, AEB3103, Kills Prostate Cancer Cells by Unleashing Oxidative Stress in Mice Study

News

Aeglea BioTherapeutics’ investigational enzyme, AEB3103, seems a promising treatment approach for a number of tumors, according to preclinical study results. The therapy suppressed tumor growth in prostate and breast cancer mouse ... Read more

November 16, 2016

Early Studies of Existing Therapy Show Promise in Treating Nerve Injury Linked to Prostate Removal

News

A drug that has been approved for the treatment of chronic nerve disease such as multiple sclerosis called 4-aminopyridine (4AP) may also be used to repair nerve injury from, for ... Read more

November 4, 2016November 4, 2016

Prostate Biopsies and Surgeries Seen to Fall in US After PSA Screening Found Wanting

News

The number of prostate biopsies and surgeries (radical prostatectomy, or RP) prescribed by doctors to diagnose and treat prostate cancer has dropped significantly since 2012, when a U.S. task force ... Read more

November 3, 2016

Clinical Trial in Prostate Cancer Patients Planned for Generic Form of Trelstar

News

Xbrane Biopharma announced that it will conduct a clinical trial in prostate cancer patients to assess Spherotide, its one-month generic formulation of Trelstar (triptorelin), to support its plans to submit a Marketing Authorization ... Read more

November 1, 2016

Trial for Prostate Cancer Vaccine Extends Patient Enrollment to Rutgers Cancer Institute

News

An ongoing Phase 1 clinical trial evaluating the experimental new vaccine MVI-118 for prostate cancer treatment has been extended to Rutgers Cancer Institute of New Jersey. Patient enrollment is currently open. The trial ... Read more

October 28, 2016

Molecular Link Found Between Prostate Cancer and Ewing’s Sarcoma, a Form of Bone Cancer

News

Proteins that contribute to the development of Ewing’s sarcoma, a form of bone cancer, also may play a role in prostate cancer, a new study suggests. The study, “An Interaction ... Read more

October 27, 2016

MNX1 Gene May Account for Higher Prostate Cancer Occurence Among African-Americans

News

Scientists have identified a gene, called MNX1, that may account for the increased incidence of prostate cancer among African-American patients, according to a new study published in the journal Cancer ... Read more

October 21, 2016

New Imaging Technology Shows High Efficiency In Detecting Prostate Cancer

News

LLTech announced the publication of a study evaluating the effectiveness of its new imaging technology in the diagnosis of prostate cancer from patient biopsies. The study, “High efficiency for prostate biopsy ... Read more

October 11, 2016

PET, MRI Combination Helps Map Prostate Cancer Relapses

News

Combining two imaging techniques has allowed researchers to study the patterns of prostate cancer recurrence following radical prostatectomy (removal of the prostate). Titled “Contemporary Mapping Of Post-Prostatectomy Prostate Cancer Relapse With C-11 Choline ... Read more

October 5, 2016October 5, 2016

Hypofractionated Radiation Shortens Prostate Cancer Treatment with Little Quality of Life Impact

News

Treating early stage prostate cancer with hypofractionated radiation therapy (HRT) results in fairly similar health-related quality of life outcomes as conventional radiation therapy (CRT), but reduces treatment time by up to ... Read more